These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 28120562)
21. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers. El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011 [TBL] [Abstract][Full Text] [Related]
22. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes. Lin X; Tang X; Jiang Q; Liu Q; Lin Z; Lin J; Chen L; Hong H Clin Lab; 2012; 58(5-6):539-44. PubMed ID: 22783586 [TBL] [Abstract][Full Text] [Related]
23. [Serum chemerin is elevated in patients with metabolic syndrome complicated by degenerative aortic valve disease]. Dong M; Xie T; Chen X; Chen X Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):651-4. PubMed ID: 24849429 [TBL] [Abstract][Full Text] [Related]
24. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases. Faber DR; van der Graaf Y; Westerink J; Visseren FL Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358 [TBL] [Abstract][Full Text] [Related]
25. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index. Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351 [TBL] [Abstract][Full Text] [Related]
26. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio. Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Maciel PM; Reaven GM Am J Med; 2014 Feb; 127(2):152-7. PubMed ID: 24462013 [TBL] [Abstract][Full Text] [Related]
27. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. Er LK; Wu S; Chou HH; Hsu LA; Teng MS; Sun YC; Ko YL PLoS One; 2016; 11(3):e0149731. PubMed ID: 26930652 [TBL] [Abstract][Full Text] [Related]
28. The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults. Lee MK; Chu SH; Lee DC; An KY; Park JH; Kim DI; Kim J; Hong S; Im JA; Lee JW; Jeon JY Clin Chim Acta; 2013 Jun; 421():109-15. PubMed ID: 23485648 [TBL] [Abstract][Full Text] [Related]
29. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Dong B; Ji W; Zhang Y Intern Med; 2011; 50(10):1093-7. PubMed ID: 21576834 [TBL] [Abstract][Full Text] [Related]
30. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. Chu SH; Lee MK; Ahn KY; Im JA; Park MS; Lee DC; Jeon JY; Lee JW PLoS One; 2012; 7(4):e34710. PubMed ID: 22509348 [TBL] [Abstract][Full Text] [Related]
31. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918 [TBL] [Abstract][Full Text] [Related]
32. Serum Cystatin C levels increase with increasing visceral fat area in patients with type 2 diabetes mellitus. Cong X; Chen X; Shen Q; Wu Y; Wang Q; Chen L Sci Rep; 2024 Aug; 14(1):18638. PubMed ID: 39128944 [TBL] [Abstract][Full Text] [Related]
33. Independent Association of Circulating Level of Chemerin With Functional and Early Morphological Vascular Changes in Newly Diagnosed Type 2 Diabetic Patients. Lu B; Zhao M; Jiang W; Ma J; Yang C; Shao J; Gu P Medicine (Baltimore); 2015 Nov; 94(47):e1990. PubMed ID: 26632694 [TBL] [Abstract][Full Text] [Related]
34. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797 [TBL] [Abstract][Full Text] [Related]
35. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213 [TBL] [Abstract][Full Text] [Related]
36. Plasma chemerin level in metabolic syndrome. Wang D; Yuan GY; Wang XZ; Jia J; Di LL; Yang L; Chen X; Qian FF; Chen JJ Genet Mol Res; 2013 Nov; 12(4):5986-91. PubMed ID: 24338392 [TBL] [Abstract][Full Text] [Related]
37. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis. Li Y; Shi B; Li S PLoS One; 2014; 9(12):e113915. PubMed ID: 25469985 [TBL] [Abstract][Full Text] [Related]
38. Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes? Kim CS; Kim SK; Araneta MR; Lee EJ; Barrett-Connor E; Huh KB J Diabetes Complications; 2015; 29(8):1085-91. PubMed ID: 26231803 [TBL] [Abstract][Full Text] [Related]
39. Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism. Takahashi M; Inomata S; Okimura Y; Iguchi G; Fukuoka H; Miyake K; Koga D; Akamatsu S; Kasuga M; Takahashi Y Endocr J; 2013; 60(1):37-44. PubMed ID: 22986456 [TBL] [Abstract][Full Text] [Related]
40. Chemerin Ratios to HDL-cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome. Shafer-Eggleton J; Adams-Huet B; Jialal I Endocr Res; 2020 Nov; 45(4):241-245. PubMed ID: 32835545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]